PHAT
Phathom Pharmaceuticals Inc
7.30$
+3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +52.9% | +15.7% | -7.9% | -3.0% | +1.0% | -8.3% | -2.8% | -9.3% | -17.9% | -14.1% | +3.6% | – | |
| – | +300.4% | -77.1% | +8.4% | -7.6% | +18.7% | -17.2% | +49.3% | +12.4% | -39.7% | -1.4% | +21.3% | – | |
| – | – | -1,138.6% | – | – | -752.4% | – | – | – | – | -61.8% | +70.4% | – | |
| – | -49.4% | -91.6% | +15.0% | +87.0% | -94.2% | +260.0% | +438.9% | -72.2% | +325.9% | -47.0% | -27.9% | – | |
| – | -49.4% | -91.6% | +15.0% | -4.3% | -88.6% | +260.0% | +438.9% | -72.2% | +222.2% | -29.9% | -27.9% | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | -100.0% | – | |
| – | +1,630,615.4% | -95.3% | +150.2% | +392.7% | -78.7% | -100.0% | – | -438.8% | -64.2% | – | -94.7% | – | |
| – | – | -135.3% | – | – | -164.0% | – | – | – | – | – | -96.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.